Adial (ADIL) Stock Skyrockets: Patent Award Fuels Surge
Adial Pharmaceuticals, Incorporated (NASDAQ: ADIL) has witnessed a remarkable upsurge in its stock valuation, experiencing a noteworthy surge of 169.28% to $2.28 per share during the current session of trading. This surge can be primarily attributed to the disclosure of the grant of a novel patent to Adial within the United States. Adial (ADIL) officially […]
Adial (ADIL) Stock Skyrockets: Patent Award Fuels Surge Read More »